IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
0.7290
-0.0400 (-5.20%)
Nov 20, 2026, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 108.41 million as of November 20, 2026. It is the 40,694th most valuable company in the world and the 589th biggest in Sweden. Its market cap has decreased by 43.52% in one year.
Market Cap
108.41M
Enterprise Value
35.70M
Revenue
67.42M
Global Rank
Country Rank
#589 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 108.41M, a decrease of -73.75%. That is a compound annual growth rate of -12.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 108.41M | -35.21% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abera Bioscience AB | 140.62M |
| Diamyd Medical AB | 138.25M |
| BioInvent International AB | 137.53M |
| Simris Group AB (PUBL) | 137.49M |
| Xintela AB | 121.44M |
| Alzinova AB | 97.82M |
| Active Biotech AB | 88.57M |
| Biovica International AB | 87.57M |